Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PAAD | rs181245480 | chr21:44064717 | C/T | 1.47E-12 | 174 | 15.43 | 18.45 | 1.37 | KM Plot |
| PAAD | rs182822103 | chr11:125370191 | C/T | 4.16E-5 | 173 | 15.53 | 15.13 | 3.9 | KM Plot |
| PAAD | rs183055947 | chr1:227446561 | C/A | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |
| PAAD | rs185245936 | chr1:227572379 | A/AC | 6.96E-5 | 176 | 15.4 | 16.45 | 3.9 | KM Plot |
| PAAD | rs185741477 | chr17:27067070 | G/A | 1.59E-5 | 176 | 15.42 | 16.07 | 3.67 | KM Plot |
| PAAD | rs186169334 | chr1:227224414 | A/G | 4.08E-5 | 176 | 15.55 | 15.43 | 3.9 | KM Plot |
| PAAD | rs187228731 | chr5:60189897 | C/T | 6.74E-5 | 175 | 15.27 | 16.15 | 4.68 | KM Plot |
| PAAD | rs187393805 | chr12:106022732 | T/G | 3.11E-6 | 175 | 15.37 | 16.6 | 5.03 | KM Plot |
| PAAD | rs187404880 | chr11:125581858 | A/T | 4.72E-5 | 178 | 16.03 | 11.6 | 4.1 | KM Plot |
| PAAD | rs187794686 | chr2:128525162 | G/A | 7.9E-10 | 178 | 15.62 | 12.6 | 2.2 | KM Plot |
| PAAD | rs188895843 | chr4:78451783 | A/G | 2.53E-5 | 178 | 15.57 | 14.63 | 3.9 | KM Plot |
| PAAD | rs1894430 | chr4:2403270 | A/G | 0 | 178 | 0.4 | 16.1 | 15.37 | KM Plot |
| PAAD | rs189865352 | chr1:227320944 | C/T | 3.2E-5 | 178 | 15.53 | 15.65 | 3.9 | KM Plot |
| PAAD | rs190900607 | chr10:94195134 | A/G | 9.19E-6 | 175 | 14.9 | 19.87 | 4.38 | KM Plot |
| PAAD | rs193041540 | chr1:227463352 | A/G | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |